Lassa mammarenavirus
| Amantadine | LASV | Viroporin inhibitor; blocks viral ion channel activity | Approved (other) | Japan | Viral ion channel (viroporin) | |
| Amiloride | LASV | Epithelial sodium channel inhibitor | Preclinical | — | Human ion channel | |
| Amodiaquine | LASV | Methyltransferase inhibitor | Preclinical | — | Human HNMT | |
| Apilimod | LASV | PIKfyve kinase inhibitor | Preclinical | — | Human PTK | |
| Brequinar | LASV | DHODH (DHODH) inhibitor | Preclinical | — | Human DHODH | |
| CR-1-31-B | LASV | Prevents mRNA translation | Preclinical | — | Human ATPase | |
| Favipiravir | LASV | Viral RNA polymerase inhibitor | Approved (other) | Japan | Viral RNA pol | |
| Merimepodib | LASV | IMPDH inhibitor | Preclinical | — | Human IMPDH | |
| Mycophenolic acid | LASV | Inosine monophosphate dehydrogenase inhibitor | Preclinical | — | Human IMPDH | |
| Niclosamide | LASV | — | Preclinical | — | Human (multiple) | |
| Obatoclax | LASV | Bcl-2 family inhibitor | Preclinical | — | Human MCL1 | |
| Remdesivir | LASV | Viral RNA polymerase inhibitor | Approved (other) | Japan | Viral RNA pol | |
| Ribavirin | LASV | Nucleoside inhibitor; Guanosine (ribonucleic) analog | Approved (other) | JapanChinaRussia | Viral RNA pol | |
| Silvestrol | LASV | RNA helicase inhibitor | Preclinical | — | Human EIF4A | |
| Umifenovir | LASV | — | Preclinical | — | Human (multiple) |